Beyond tradition and convention : benefits of non-traditional model organisms in cancer research
Traditional laboratory model organisms are indispensable for cancer research and have provided insight into numerous mechanisms that contribute to cancer development and progression in humans. However, these models do have some limitations, most notably related to successful drug translation, because traditional model organisms are often short-lived, small-bodied, genetically homogeneous, often immunocompromised, are not exposed to natural environments shared with humans, and usually do not develop cancer spontaneously. We propose that assimilating information from a variety of long-lived, large, genetically diverse, and immunocompetent species that live in natural environments and do develop cancer spontaneously (or do not develop cancer at all) will lead to a more comprehensive understanding of human cancers. These non-traditional model organisms can also serve as sentinels for environmental risk factors that contribute to human cancers. Ultimately, expanding the range of animal models that can be used to study cancer will lead to improved insights into cancer development, progression and metastasis, tumor microenvironment, as well as improved therapies and diagnostics, and will consequently reduce the negative impacts of the wide variety of cancers afflicting humans overall.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Cancer metastasis reviews - 40(2021), 1 vom: 28. März, Seite 47-69 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Harman, Rebecca M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Cancer |
---|
Anmerkungen: |
Date Completed 25.11.2021 Date Revised 25.11.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1007/s10555-020-09930-6 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM316798150 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM316798150 | ||
003 | DE-627 | ||
005 | 20231225161845.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s10555-020-09930-6 |2 doi | |
028 | 5 | 2 | |a pubmed24n1055.xml |
035 | |a (DE-627)NLM316798150 | ||
035 | |a (NLM)33111160 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Harman, Rebecca M |e verfasserin |4 aut | |
245 | 1 | 0 | |a Beyond tradition and convention |b benefits of non-traditional model organisms in cancer research |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.11.2021 | ||
500 | |a Date Revised 25.11.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Traditional laboratory model organisms are indispensable for cancer research and have provided insight into numerous mechanisms that contribute to cancer development and progression in humans. However, these models do have some limitations, most notably related to successful drug translation, because traditional model organisms are often short-lived, small-bodied, genetically homogeneous, often immunocompromised, are not exposed to natural environments shared with humans, and usually do not develop cancer spontaneously. We propose that assimilating information from a variety of long-lived, large, genetically diverse, and immunocompetent species that live in natural environments and do develop cancer spontaneously (or do not develop cancer at all) will lead to a more comprehensive understanding of human cancers. These non-traditional model organisms can also serve as sentinels for environmental risk factors that contribute to human cancers. Ultimately, expanding the range of animal models that can be used to study cancer will lead to improved insights into cancer development, progression and metastasis, tumor microenvironment, as well as improved therapies and diagnostics, and will consequently reduce the negative impacts of the wide variety of cancers afflicting humans overall | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a Cancer | |
650 | 4 | |a Cancer resistance | |
650 | 4 | |a Metastasis | |
650 | 4 | |a Non-traditional model organisms | |
650 | 4 | |a Sentinel | |
650 | 4 | |a Spontaneous tumors | |
650 | 4 | |a Tumor microenvironment | |
700 | 1 | |a Das, Sanjna P |e verfasserin |4 aut | |
700 | 1 | |a Bartlett, Arianna P |e verfasserin |4 aut | |
700 | 1 | |a Rauner, Gat |e verfasserin |4 aut | |
700 | 1 | |a Donahue, Leanne R |e verfasserin |4 aut | |
700 | 1 | |a Van de Walle, Gerlinde R |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancer metastasis reviews |d 1995 |g 40(2021), 1 vom: 28. März, Seite 47-69 |w (DE-627)NLM013060104 |x 1573-7233 |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2021 |g number:1 |g day:28 |g month:03 |g pages:47-69 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s10555-020-09930-6 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2021 |e 1 |b 28 |c 03 |h 47-69 |